Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on July 11, 2025

Sebastian Nunez Injury Law Firm Officially Launches in El Paso, Bringing Trial-Tested Expertise to Injury Victims
After litigating high-stakes cases on behalf of major corporations, Nunez has officially launched his own personal injury firm: Sebastian Nunez Injury Law. EL PASO, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- After years of litigating high- …

PitPat Launches July Week2 Open Trials 10km: Bringing Global Runners Together for Glory, Challenge, and Real Rewards
HOUSTON, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- As the world’s leading virtual competition platform, PitPat is dedicated to breaking the barriers of distance and time through technology and innovation. By making running, cycling, rowing, …

Sol Endocrinology Offers Comprehensive Lipedema Consultation in Dallas, Texas
Sol Endocrinology offers expert lipedema diagnosis and care in Dallas, led by Dr. Erin Roe, empowering women with relief and personalized treatment. DALLAS, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- Sol Endocrinology, led by renowned …

FitnessGram® Launches National Ambassador Program - FitnessGram Core®
Spotlighting Excellence in Physical Education DALLAS, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- FitnessGram®, by GreenLight Fitness—the nation's leading youth fitness assessment platform—proudly announces the launch of the FitnessGram Core …

Mobility City of Rio Grande Valley Now Brings Fast, Reliable Mobility Equipment Repairs to South Texas Veterans
Mobility City owner Armando Alfaro, by partnering for repair services with local VA facilities, helps Veterans retain independence and mobility. RIO GRANDE VALLEY, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- Mobility City of Rio Grande Valley …

Mobility City of Montgomery TX Delivers Medical Mobility Repair Services to Veterans Addressing Safety and Comfort
Owners Salina …

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a …

Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in any capacity, due to extenuating …

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable FDA clinical reviews acknowledged that the clinical data are robust and biomarker data are supportive NOVATO, Calif., July 11 …

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
JENA, Germany, July 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has received a written notice (the “Notice”), …

4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WOBURN, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health …

Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales and Clinical Trials Insight 2030 Report Finding …

Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Market Trends Report
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report: Report Answers Question On Why There Exist Need For Bispecific Antibody Drug …

Safest Steroid for Muscle Growth and Bodybuilding - Clinical Evidence and Safety Behind CrazyBulk's Bulking Steroids
New York City, NY, July 11, 2025 (GLOBE NEWSWIRE) -- For decades, the use of muscle building steroids has been a driving force behind the pursuit of muscle growth and physical prowess among bodybuilders, athletes, and sports professionals. Whether …

Cancer Photodynamic Therapy Clinical Trials Market Size FDA Approval Market Report Insight
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Cancer Photodynamic Therapy Market …

Valneva annonce la levée de la restriction temporaire de l'Agence européenne des médicaments sur l'utilisation du vaccin contre le chikungunya IXCHIQ® chez les personnes âgées
Saint Herblain (France), le 11 juillet 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence européenne des médicaments (EMA) …

Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above …